Key phases of clinical trails
At Vertex Clinical Research, we specialize in conducting Phase II, III, and IV clinical trials with precision, efficiency, and full regulatory compliance. Our experienced team partners with sponsors and CROs to ensure every phase delivers reliable data, strong patient retention, and seamless execution from site initiation to final reporting.
Advancing from Discovery to Proof of Concept
Our Phase II studies focus on evaluating the safety and efficacy of new therapies intargeted patient groups. Vertex ensures high-quality data capture, ethical oversight, and rapid enrollment —providing sponsors with robust insights to support go/no-go decisions.
Confirming Effectiveness in Real-World Populations
In Phase III trials, we validate clinical outcomes in diverse patient populations underreal-world conditions. Vertex’s large network, advanced infrastructure, and strict adherence to ICH-GCP standards ensure timely recruitment, consistent monitoring, and audit-ready data for regulatory submissions.
Post-Marketing Studies for Long-Term Safety and Value
Our Phase IV programs evaluate treatment performance after market approval, providing sponsors with post-launch safety, adherence, and quality-of-life insights.
205, Francisco de Urdinola, Del Valle, 78200, San Luis Potosí, Mexico